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Abstract
Objective: To identify and characterize alterations seen on HRCT scans in nonsmoking females with COPD 
due to wood smoke exposure. Methods: We evaluated 42 nonsmoking females diagnosed with wood smoke-
related COPD and 31 nonsmoking controls with no history of wood smoke exposure or pulmonary disease. The 
participants completed a questionnaire regarding demographic data, symptoms, and environmental exposure. 
All of the participants underwent spirometry and HRCT of the chest. The COPD and control groups were 
adjusted for age (23 patients each). Results: Most of the patients in the study group were diagnosed with mild 
to moderate COPD (83.3%). The most common findings on HRCT scans in the COPD group were bronchial wall 
thickening, bronchiectasis, mosaic perfusion pattern, parenchymal bands, tree-in-bud pattern, and laminar 
atelectasis (p < 0.001 vs. the control group for all). The alterations were generally mild and not extensive. 
There was a positive association between bronchial wall thickening and hour-years of wood smoke exposure. 
Centrilobular emphysema was uncommon, and its occurrence did not differ between the groups (p = 0.232). 
Conclusions: Wood smoke exposure causes predominantly bronchial changes, which can be detected by HRCT, 
even in patients with mild COPD.
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Resumo
Objetivo: Identificar e caracterizar alterações na TCAR de tórax em mulheres com DPOC causada por exposição à 
fumaça da combustão de lenha. Métodos: Foram selecionadas 42 pacientes com DPOC relacionada à exposição 
à fumaça de lenha, não fumantes, e 31 mulheres não fumantes e sem história de exposição à fumaça de lenha 
ou de doença pulmonar. Empregou-se um questionário para a obtenção de dados demográficos e informações 
sobre sintomas e exposições ambientais. Todas as participantes realizaram espirometria e TCAR de tórax. Os 
grupos DPOC e controle foram ajustados por idade, com 23 pacientes cada. Resultados: A maioria das pacientes 
do grupo de estudo apresentava DPOC de leve a moderado (83,3%). Os achados de TCAR mais frequentes 
no grupo DPOC foram espessamento das paredes brônquicas, bronquiectasias, perfusão em mosaico, bandas 
parenquimatosas, padrão de árvore em brotamento e atelectasias laminares (p < 0,001 para todos na comparação 
com o grupo controle). As alterações, em geral, foram leves e de pequena extensão. Houve uma associação 
positiva entre espessamento das paredes brônquicas e duração da exposição à fumaça de lenha em horas-ano. 
O achado de enfisema centrolobular foi infrequente e não diferiu entre os grupos (p = 0,232). Conclusões: A 
exposição à fumaça de lenha provoca alterações predominantemente brônquicas, que podem ser detectadas 
por TCAR, mesmo nos casos de DPOC leve.
Descritores: Biomassa; Fumaça; Tomografia computadorizada por raios X; Doença pulmonar obstrutiva 
crônica.
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Methods
The present study was conducted in central 
Brazil between 2008 and 2011. The inclusion 
criteria for COPD patients were as follows: being 
≥ 40 years of age; having been exposed to wood 
smoke ≥ 80 hour-years for at least 10 years; not 
being a smoker; and having received a clinical 
and spirometric diagnosis of COPD. The inclusion 
criteria for controls were as follows: being ≥ 40 
years of age; living in an urban area; not being a 
smoker; having no history of wood smoke exposure; 
and having normal spirometry results. All of the 
females who participated in the present study 
gave written informed consent. The exclusion 
criteria for COPD patients and controls were as 
follows: presenting with clinical findings (of an 
evaluation performed by a pulmonologist in the 
present study or of a previous evaluation by a 
pulmonologist, as reported in the medical records) 
suggestive of a history of asthma, rhinitis, or any 
extrapulmonary disease that might affect lung 
function; and having a positive bronchodilator 
test, FEV1 increasing by ≥ 12% and 200 mL.
(15) 
We used a shorter version of a questionnaire 
that was previously used in a population-based 
study conducted in Brazil(16) in order to collect 
demographic and clinical data: respiratory 
symptoms (cough, phlegm, wheezing, and dyspnea), 
duration (in years and daily hours) of exposure 
to wood smoke; duration (in years) of exposure 
to passive smoking by living in a household with 
smokers; and duration (in years) of residence in a 
rural area. The degree of dyspnea was quantified 
by the Medical Research Council (MRC) scale.(17) 
The cumulative exposure to wood smoke 
was expressed in hour-years, calculated as the 
number of years cooking with a wood stove 
multiplied by the mean number of hours the 
participant reported to spend, daily, in this 
activity. The criterion of wood smoke exposure 
≥ 80 hour-years for at least 10 years was based 
on the levels of exposure considered significant 
in similar studies.(18) 
The study participants underwent spirometry 
before and after the use of a bronchodilator 
(albuterol, 400 µg), FVC, FEV1, and the FEV1/
FVC ratio being measured. The diagnostic criteria 
for COPD were as follows: being ≥ 40 years of 
age; having an FEV1/FVC ratio below the lower 
limit of normality and < 0.70(19,20); having been 
exposed to smoke from wood stoves; and having 
Introduction
In developing countries, biomass is still 
widely used as a source of energy for cooking 
and indoor heating. It is estimated that half 
of the world population uses biomass, which 
consists of unprocessed wood (firewood) or 
processed wood (charcoal), dung, and crop 
residues.(1) 
Numerous studies have shown that, among 
females exposed to biomass smoke, the prevalence 
of COPD is high and the risk of developing 
the disease is significantly increased.(2) It is 
estimated that 25-45% of all COPD patients 
have never smoked.(3) It is also known that 
the number of people who are exposed to 
smoke from biomass combustion is significantly 
higher than is that of those who are exposed 
to tobacco smoke (approximately 3 billion vs. 
1.01 billion).(3) 
There is a growing interest in learning 
more about the structural changes resulting 
from the inhalation of biomass smoke in 
order to gain a deeper understanding of the 
pathophysiology of biomass smoke-related 
obstructive lung disease.(4) We searched the 
literature for studies employing HRCT in order to 
evaluate pulmonary changes caused by biomass 
smoke exposure and found only ten studies.(5-14) 
However, nine of those studies are related to 
the use of a combination of types of biomass 
(dung, crop residues, and firewood), and only 
one of those studies examined exposure to 
wood smoke alone (in 12 women).(9) This 
heterogeneity of sources of smoke exposure 
makes it difficult to compare the individuals 
studied. The abovementioned study showed 
that bronchial lesions are more common in 
individuals who inhale wood smoke, whereas 
alveolar lesions are more common in cigarette 
smokers.(9) However, to our knowledge, there 
have been no CT studies of lung lesions in 
COPD patients exposed to wood smoke, the 
findings in such patients being compared 
with those in a control group of nonsmoking 
females with no history of exposure to biomass 
smoke. 
The objective of the present study was to 
identify and characterize alterations seen on 
HRCT scans in nonsmoking females with COPD 
due to prolonged exposure to wood smoke from 
cooking. 
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images were of 10 mm, with the patient in the 
supine position. The images were reconstructed 
with a high-resolution algorithm, with a 512 × 512 
pixel matrix. Lung and mediastinal window images 
were available for analysis. No contrast agent 
was used. 
The images were independently analyzed 
by three radiologists (one general radiologist 
with 35 years of experience and two thoracic 
radiologists, one with 2 years of experience and 
the other with 12 years of experience). In cases of 
discordance, the result was based on consensus. (25) 
All images were evaluated in Digital Imaging 
and Communications in Medicine format. The 
radiologists had no information regarding the 
clinical diagnosis of the study participants or 
the existence of risk factors for COPD. They were 
aware of the fact that it was a study aimed at 
evaluating females exposed to wood smoke. 
For the statistical analysis, we used the IBM 
SPSS Statistics software package, version 15.0 
(IBM Corporation, Armonk, NY, USA). We used 
the Student’s t-test in order to compare the 
groups in terms of quantitative variables with 
normal distribution and the Mann-Whitney U 
test in order to compare the groups in terms 
of variables with non-normal distribution. The 
chi-square test and Fisher’s exact test were 
used in order to compare the frequencies of 
qualitative variables and calculate the risk that 
the independent variable represented. By logistic 
regression analysis, we analyzed the association 
between abnormal HRCT findings and other 
variables. We used Pearson’s test in order to 
detect correlations among variables with normal 
distribution. In order to balance the sample, the 
females in the COPD group and those in the 
control group were matched for age. The oldest 
females in both groups were excluded, as were 
the youngest. The odds ratio was calculated 
with a confidence interval of 95%, and values 
of p < 0.05 were considered significant. 
The present study was approved by the Research 
Ethics Committee of the Federal University of 
Goiás Hospital das Clínicas on April 4, 2008 and 
on September 21, 2010 (Amendment 1), under 
registration no. 018/08. 
Results
In the present study, the COPD group comprised 
42 females and the control group comprised 31. 
It was extremely difficult to recruit females from 
a history of chronic dyspnea, chronic cough, or 
both, unrelated to other causes. 
The severity of COPD was determined 
in accordance with the Global Initiative for 
Chronic Obstructive Lung Disease spirometric 
classification. (20) 
The pulmonary function tests were performed 
in accordance with the Brazilian Thoracic 
Association guidelines.(21) The predicted values 
used in the present study were those of Pereira 
et al.(22) 
In our analysis of HRCT scans, we used the 
criteria established by the Brazilian Thoracic 
Association illustrated Brazilian consensus of 
terms and fundamental patterns in chest CT 
scans.(23) In order to locate abnormalities, we used 
the following criteria: upper lung fields—from 
the apices to the carina; middle lung fields—
from the carina to the mitral valve; and lower 
lung fields—from the mitral valve to the lung 
bases. The degree of pulmonary impairment was 
determined on the basis of the number of lung 
lobes showing the following changes: parenchymal 
bands; mosaic perfusion pattern; atelectasis; 
tree-in-bud pattern; and traction bronchiectasis. 
The degree of bronchial wall thickening was 
classified as follows: grade 1—up to 20% of 
the diameter of the adjacent pulmonary artery; 
grade 2—greater than 20% and less than 50% of 
the diameter of the adjacent pulmonary artery; 
and grade 3—50-100% of the diameter of the 
adjacent pulmonary artery. Bronchiectasis was 
graded as follows: grade 1—the ratio between 
the internal diameter of the bronchus and the 
diameter of the adjacent artery was 0.7-1.0; grade 
2—the internal diameter of the bronchus was 
increased but was less than twice the diameter 
of the adjacent artery; and grade 3—the internal 
diameter of the bronchus was more than twice 
the diameter of the adjacent artery. Centrilobular 
emphysema was classified as follows(24,25): absent; 
areas of < 5 mm; areas > 5 mm; diffuse areas 
of low attenuation that were not interspersed 
with areas of normal lung; and large, confluent 
areas of low attenuation. 
In order to take HRCT scans, we used either 
a Somatom Emotion™ 6 CT scanner (Siemens, 
Munich, Germany) or an Aquilion™ 16 CT scanner 
(Toshiba, Tokyo, Japan). The images were acquired 
during a maximal inspiratory maneuver, as 
follows: collimation, 1 mm; 125 kV; 160 mA; 
and acquisition time, 0.75 s. The intervals between 
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expectoration; wheezing; and dyspnea. Dyspnea 
was the most common complaint (Table 1), the 
Medical Research Council scale scores showing 
grade 1 or 2 dyspnea in 75% of the cases and 
grade 3 or 4 in 25%. 
The females in the COPD group had mild 
to moderate airflow limitation (as determined 
by spirometry); none of the patients had severe 
obstructive lung disease (Table 1). 
Regarding HRCT abnormalities, bronchiectasis, 
mosaic perfusion pattern, linear atelectasis (lobar 
atelectasis in one patient), and tree-in-bud pattern 
were significantly more common in the females 
in the COPD group than in those in the control 
group. None of the participants had panlobular 
emphysema. Lower lobe lesions predominated 
(Table 2 and Figure 1). 
In the COPD group, we found statistically 
significant associations between bronchial wall 
thickening and cough (p = 0.013; OR = 6.13; 
95% CI: 1.46-25.73) and between bronchial 
wall thickening and hour-years of wood smoke 
exposure (p = 0.018; OR = 1.01; 95% CI: 1.01-
1.02). We also found significant associations 
between centrilobular emphysema and duration of 
passive smoking (p = 0.033; OR = 1.08; 95% CI: 
among those living in the region where the study 
was conducted, particularly elderly females who 
had never cooked with wood stoves. 
The participants were sequentially recruited 
from among those being treated at either of two 
general clinical medicine outpatient clinics and 
from among those being treated at the gynecology 
outpatient clinic of a university hospital, as well 
as being recruited from among patients without 
a confirmed diagnosis of respiratory disease 
seeking the aforementioned university hospital 
for spirometry. The females in the control group 
were selected from among those studying at an 
open university for the elderly. 
The mean age was higher in the COPD group 
than in the control group (70.8 ± 8.5 years 
vs. 58.9 ± 7.2 years; p < 0.001), as was the 
mean duration (in years) of rural residence (40.7 
± 17.7 years vs. 3.61 ± 5.1 years; p = 0.001). All 
of the females in the COPD group resided in rural 
areas and worked predominantly as housecleaners 
or homemakers, sporadically working in the 
agricultural production of grains. There were 
no statistically significant differences between 
the COPD and control groups regarding the 
mean duration of passive exposure to tobacco 
smoke (20.6 ± 18.0 years vs. 29.2 ± 21.0 years; 
p = 0.70; Table 1). 
Most of the patients with COPD had one or 
more of the following respiratory symptoms: cough; 
Table 1 - Demographic characteristics, clinical 
characteristics, and data regarding wood smoke 
exposure in 42 patients with COPD.a
Variable Result
Age, years 70.8 ± 8.5
Rural residence, years 40.7 ± 17.7
Passive smoking, years 29.2 ± 21.0
Wood smoke exposure, h/day 6.0 ± 1.9
Wood smoke exposure, years 35.1 ±12.5
Wood smoke exposure, hour-years 209.1 ± 98.4





Stage I (mild) 9 (21.4)
Stage II (moderate) 26 (61.9)
Stage III (severe) 7 (16.7)
Stage IV (very severe) 0 (0.0)
aValues expressed as mean ± SD, except where otherwise 
indicated. bValues expressed as n (%).





(n = 42) (n = 31)
Normal 0 (0.0) 1 (3.2) 0.417
Parenchymal bands 33 (78.6) 7 (22.6) < 0.001*
Bronchial wall 
thickening
28 (66.7) 0 (0.0) < 0.001
Nodules 26 (61.9) 23 (74.2) 0.320
Bronchiectasis 23 (54.8) 4 (12.9) < 0.001**
Traction 
bronchiectasis
7 (16.7) 0 (0.0) 0.018
Apical fibrosis/
pleural scarring
21 (50.0) 15 (48.4) 1.000
Mosaic perfusion 
pattern
19 (45.2) 0 (0.0) < 0.001
Atelectasis 12 (28.6) 0 (0.0) 0.001
Tree-in-bud pattern 9 (21.4) 1 (3.2) 0.037***
Mediastinal 
lymphadenopathy
6 (14.3) 2 (6.5) 0.454
Centrilobular 
emphysema
5 (11.9) 1 (3.2) 0.232
Ground-glass opacity 0 (0.0) 2 (6.5) 0.117
aValues expressed as n (%). *OR = 12.57 (95% CI: 4.11-
38.49). **OR = 8.17 (95% CI: 2.43-27.49). ***OR = 8.18 
(95% CI: 0.98-68.49).
Pulmonary changes on HRCT scans in nonsmoking 
females with COPD due to wood smoke exposure
J Bras Pneumol. 2013;39(2):155-163
159
1.01-1.16) and between mosaic perfusion pattern 
and lower FEV1 values (p = 0.009; OR = 0.93; 
95% CI: 0.89-0.98). 
In order to avoid bias due to possible structural 
lung changes occurring with age, we divided the 
participants into two new groups. Each group 
comprised 23 patients, the two groups being 
matched for age (Table 3). 
After age matching, parenchymal bands, 
bronchial wall thickening, bronchiectasis, mosaic 
perfusion pattern, and laminar atelectasis were 
found to be significantly more common in the 
COPD group than in the control group. As can 
be seen in Table 4, those abnormalities occurred 
predominantly in the lower lung fields (in 76.6%), 
having occurred in the middle lung fields in 
15.6% and in the upper lung fields in 7.8%. 
Figure 1 - Axial HRCT scans of the chest (lung window) at the level of the lower lung fields. In A, 
bronchiectasis and bronchial wall thickening (thick arrow), parenchymal bands (thin arrow), and 
mosaic perfusion pattern (asterisks) in a 66-year-old female patient. In B, middle lobe atelectasis (thick 
arrow) and bronchial wall thickening (thin arrow) in a 76-year-old female patient. In C, parenchymal 
bands (thick arrow), moderate bronchial wall thickening (thin arrow), and mosaic perfusion pattern 
(asterisks) in a 57-year-old female patient. In D, centrilobular micronodules with tree-in-bud pattern 
in an 81-year-old female patient.
The proportion of nodules on HRCT scans in 
the COPD group was equal to that of those on 
HRCT scans in the control group, most of the 
nodules being micronodules or calcified nodules. 
Discussion
The present study examined pulmonary 
changes seen on HRCT scans in females with 
wood smoke-related COPD and showed that 
those changes were significantly more severe in 
those females than in those in the control group, 
who had no history of wood smoke exposure. 
The most common findings were parenchymal 
bands, bronchial wall thickening, bronchiectasis, 
mosaic attenuation/perfusion pattern, and linear 
atelectasis, the differences between the two groups 
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studies, which have suggested that such changes 
correspond to an initial interstitial involvement.(5,6) 
Although we found no areas of significant 
interstitial involvement in the present study, three 
studies have described such areas.(5-7) Parenchymal 
bands and ground-glass opacities were also found 
in those studies, having been reported to be 
quite common in one of the studies.(6) In the 
present study, we found no ground-glass opacities, 
which are associated with interstitial thickening 
and alveolar collapse.(23) However, the females 
investigated in the abovementioned studies(5-7) had 
been exposed to mixed biomass, which includes 
dung and wood. Dung combustion generates 
more pollutants than does wood combustion, 
ranking lower on the energy scale for being less 
efficient and more polluting.(27) The differences 
among the results obtained can be explained 
by the different types of biomass used and the 
different purposes for which it is used. 
Bronchial wall thickening was the second 
most common finding in the present study, 
having remained so after adjustment for age. 
This shows that bronchial wall thickening was 
unrelated to aging. 
Bronchiectasis has been found in all studies 
examining exposure to biomass smoke(5-7) and 
was the fourth most prevalent type of lesion in 
the present study, having been found in 54.8% 
of the females exposed to wood smoke and 
in 12.5% of those in the control group. Even 
after adjustment for age, bronchiectasis was 
significantly more common in the group of 
females exposed to wood smoke. This shows 
that bronchiectasis is not associated with lung 
aging. Unlike bronchiectasis resulting from a 
specific disease, which tends to accumulate in 
a localized area of the lung, the bronchiectasis 
found in the present study was homogeneously 
distributed in the lungs and was predominantly 
located in the lower lobes. 
Mosaic perfusion pattern, which has been 
described as a CT manifestation of obstructive 
lung disease,(23) was found in nearly half of the 
COPD patients in the present study and was 
found to be independent of age. 
In the present study, atelectasis was found only 
in the COPD group, having persisted after age 
matching. The presence of bronchial anthracosis, 
which causes atelectasis, has been reported in 
females exposed to biomass smoke.(28) 
It is known that wood combustion produces 
various substances that are harmful to the 
lungs, including carbon monoxide, nitrogen 
oxide, particulate matter, polycyclic aromatic 
hydrocarbons, and formaldehyde, and that are 
also present in cigarette smoke; wood smoke 
exposure can therefore cause changes that are 
similar to those caused by smoking.(26) 
In the present study, the most common findings 
were parenchymal bands, which are changes 
indicative of parenchymal fibrosis.(23) These changes 
have been associated with exposure to biomass 
smoke and wood smoke in pathological and CT 
Table 3 - Demographic characteristics, data regarding 
wood smoke exposure, data regarding passive smoking, 
and pulmonary function test results in the COPD and 




(n = 23) (n = 23)












209.7 ± 110.5 - -
Passive 
smoking
26.5 ± 19.9 21.7 ± 20.3 0.424
FVC, % of 
predicted
91.8  ± 13.1 99.4 ± 15.3 < 0.001
FEV1, % of 
predicted
65.9 ± 15.1 104.5 ± 12.6 < 0.001
FEV1/FVC 0.58 ± 0.1 0.80 ± 0.1 < 0.001
aValues expressed as mean ± SD.
Table 4 - HRCT findings in the COPD and control 




(n = 23) (n = 23)
Parenchymal bands 20 (86.9) 4 (17.4) < 0.001*
Bronchial wall 
thickening
14 (60.9) 0 (0.0) < 0.001
Bronchiectasis 10 (43.5) 4 (17.4) 0.047**
Mosaic perfusion 
pattern
7 (30.4) 0 (0.0) 0.009
Atelectasis 7 (30.4) 0 (0.0) 0.009
Tree-in-bud pattern 5 (21.7) 1 (4.3) 0.187
aValues expressed as n (%). *OR = 22.56 (95% CI: 4.91-
103.66). **OR = 5.13 (95% CI: 1.18-22.24).
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abnormalities, which are also seen in patients 
with smoking-related COPD.(4) 
The proportion of apical fibrosis/pleural scarring 
seen in the COPD group was the same as that seen 
in the control group, as was the proportion of 
tree-in-bud pattern. Those changes might be due 
to pulmonary tuberculosis or infectious bronchitis. 
However, none of the females investigated in the 
present study reported a history of tuberculosis, 
and none had a clinical profile suggestive of 
active tuberculosis or bronchial infection. 
The present study has limitations. Some of the 
data were collected by means of a questionnaire, 
and questionnaires depend on the ability of 
respondents to recollect specific information. 
This problem is mitigated by the fact that the 
questionnaire used in the present study had 
previously been used in Brazil and by the fact 
that the interviewers were extensively trained 
in order to obtain information by objectively 
referring to specific aspects of the lives of the 
participants. Another limitation of the present 
study was the lack of an objective measurement of 
the degree of pollution at the place of residence 
of the females who used wood stoves. Finally, we 
did not take HRCT scans during an expiratory 
maneuver. Such scans facilitate the visualization 
of small airway abnormalities. However, blinded 
individual assessment, followed by consensus 
among three experienced radiologists, probably 
minimized this limitation. 
Relevant aspects of the present study were 
the fact that all patients and controls underwent 
spirometry; we collected data regarding exposure 
to wood smoke only, data regarding other types of 
exposure having been excluded; and we established 
a minimum duration of exposure to wood smoke 
as a criterion for inclusion in the present study. 
Another relevant aspect of the present study is that 
we found no similar studies in the literature. In our 
study, we evaluated a control group of nonsmoking 
females with no history of exposure to biomass 
smoke, having performed adjustment for age and 
having used HRCT scans in order to describe the 
effects of exposure to wood smoke alone on the 
lungs of nonsmoking females with COPD.
We can conclude that wood smoke inhalation 
causes lung legions predominantly in the airways. 
These lesions can be detected by HRCT, even in 
patients with mild to moderate COPD. This finding 
is important because it shows that individuals 
exposed to wood smoke can present with pulmonary 
A study of women exposed to wood smoke 
found “pseudoemphysema” and hyperinflation 
on CT scans, and it was suggested that those 
changes were due to pronounced bronchial 
involvement, given that there were no changes 
in lung elastic recoil, which are typically seen in 
cases of emphysema.(9) Emphysema is an unusual 
finding in individuals exposed to biomass smoke 
and, when present, is usually less pronounced 
than is that observed in individuals with smoking-
related COPD.(9) 
In the present study, we found centrilobular 
emphysema, which was positively associated with 
duration of passive smoking. Although it was weak, 
this association suggests that passive smoking 
contributes to the development of emphysema. 
Another relevant finding of the present study was 
the association between bronchial wall thickening 
and chronic cough. We found a weak but positive 
association between bronchial wall thickening 
and duration of exposure to biomass smoke. This 
finding had not been reported in the literature, 
an association between obstructive functional 
impairment and duration of exposure to biomass 
smoke having previously been reported.(6) 
We found an association between mosaic 
perfusion pattern, which is suggestive of obstructive 
lung disease,(23) and lower FEV1 and FEV1/FVC 
values. 
Age-related CT abnormalities, principally 
bronchial abnormalities, have been reported in 
individuals over 65 years of age, regardless of 
their smoking history.(26) However, even after 
adjustment for age, the difference between 
the COPD and control groups regarding the 
frequency of changes persisted, the exception 
being tree-in-bud pattern. This demonstrated 
that the changes previously seen in the COPD 
group were related to wood smoke exposure 
rather than to aging. 
One study established a relationship between 
various COPD phenotypes and CT findings.(29) One 
of those phenotypes, reported in nonsmokers, 
included minimal emphysema, bronchial wall 
thickening, mild hyperinflation, and high body 
mass index values. The abovementioned phenotype 
partly coincides with the phenotype found in 
the present study. 
Most of the patients in the present study 
had mild to moderate COPD. This can partially 
explain why those patients had milder HRCT 
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